In vivo coordination structural changes of a potent insulin-mimetic agent, bis(picolinato)oxovanadium(IV), studied by electron spin-echo envelope modulation spectroscopy

Journal of Inorganic Biochemistry

Volumn 77, Issue 3-4, 1999, Pages 215-224

  Fukui, Kôichi ^a   Fujisawa, Yae ^b   Ohya Nishiguchi, Hiroaki ^a   Kamada, Hitoshi ^a   Sakurai, Hiromu ^b  

^a Inst for Life Support Technology   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Diabetes; ESEEM; Insulin; Oxovanadium(IV) complex; Pulsed EPR

Indexed keywords

BIS(PICOLINATO)OXOVANADIUM; HYDROXYAPATITE; INSULIN; PICOLINIC ACID; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE;

ARTICLE; DECOMPOSITION; DIABETES MELLITUS; ELECTRON SPIN RESONANCE; GLUCOSE BLOOD LEVEL; KIDNEY PARENCHYMA; LIVER; SIGNAL TRANSDUCTION; SPECTROSCOPY; STRUCTURE ACTIVITY RELATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ELECTRON SPIN RESONANCE SPECTROSCOPY; HYPOGLYCEMIC AGENTS; MOLECULAR MIMICRY; PICOLINIC ACIDS; RATS; RATS, WISTAR; VANADATES; VANADIUM;

EID: 0033399546     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(99)00204-4     Document Type: Article

References (39)

1. Shechter Y., Karlish S.J.D. Nature. 284:1980;556-558.
2. Dubyak G.R., Kleinzeller A. J. Biol. Chem. 255:1980;5306-5312.
3. Heylinger C.E., Tahiliani A.G., McNeill J.H. Science. 227:1985;1474-1477.
4. Sakurai H., Tsuchiya K., Nukatsuka M., Sofue M., Kawada J. J. Endocrinol. 126:1990;451-459.
5. Sakurai H., Tsuchiya K., Nukatsuka M., Kawada J., Ishikawa S., Yoshida H., Komatsu M. J. Clin. Biochem. Nutr. 8:1990;193-200.
6. Watanabe H., Nakai M., Komazawa K., Sakurai H. J. Med. Chem. 37:1994;876-877.
7. Sakurai H., Watanabe H., Tamura H., Yasui H., Matsushita R., Takada J. Inorg. Chim. Acta. 283:1998;175-183.
8. Fantus I.G., Kodaka S., Deragon G., Foster B., Posner B.I. Biochemistry. 28:1989;8864-8871.
9. Crans D.C., Keramidas A.D., Hoover-Litty H., Anderson O.P., Miller M.M., Lemoine L.M., Pleasic-Williams S., Vandenberg M., Rossomando A.J., Sweet L.J. J. Am. Chem. Soc. 119:1997;5447-5448.
10. Sakurai H., Fujii K., Watanabe H., Tamura H. Biochem. Biophys. Res. Commun. 214:1995;1095-1101.
11. Fujimoto S., Fujii K., Yasui H., Matsushita R., Takada J., Sakurai H. J. Clin. Biochem. Nutr. 23:1997;113-129.
12. McNeill J.H., Yuen V.G., Hoveyda H.R., Orvig C. J. Med. Chem. 35:1992;1489-1491.
13. Caravan P., Gelmini L., Glover N., Herring F.G., Li H., McNeil J.H., Rettig S.J., Setyawati I.A., Shuter E., Sun Y., Tracey A.S., Yuen V.G., Orvig C. J. Am. Chem. Soc. 117:1995;12759-12770.
14. G. Elberg, J. Li, Y. Shechter, in: J.O. Nriagu (Ed.), Vanadium in the Environment. Part 2: Health Effects, Wiley, Singapore, 1998, pp. 277-296.
15. H. Sakurai, K. Fujii, S. Fujimoto, Y. Fujisawa, K. Takechi, H. Yasaui, in: A.C. Tracy, D.C. Cnans (Eds.), Vanadium Compounds, Chemistry, Biochemistry, and Therapeutic Applications, ACS Symposium Series 711, American Chemical Society, Washington, DC, 1998, pp. 344-352.
16. Nakai M., Watanabe H., Fujiwara C., Kakegawa H., Satoh T., Takada J., Matsushita R., Sakurai H. Biol. Pharm. Bull. 18:1995;719-725.
17. Cantley L.C. Jr, Aisen P. J. Biol. Chem. 254:1979;1781-1784.
18. Degani H., Gochin M., Karlish S.J.D., Shechter Y. Biochemistry. 20:1981;5795-5799.
19. Sakurai H., Shimomura S., Fukuzawa K., Ishizu K. Biochem. Biophys. Res. Commun. 96:1980;293-298.
20. Fukui K., Ohya-Nishiguchi H., Nakai M., Sakurai H., Kamada H. FEBS Lett. 368:1995;31-35.
21. Astashkin A.V., Dikanov S.A., Tsvetkov Y.D. J. Struct. Chem. 26:1985;363-368.
22. Tipton P.A., McCracken J., Cornelious J.B., Peisach J. Biochemistry. 28:1989;5720-5728.
23. Fukui K., Ohya-Nishiguchi H., Kamada H. Inorg. Chem. 36:1997;5518-5529.
24. LoBrutto R., Hamstra B.J., Colpas G.J., Pecoraro V.L., Frasch W.D. J. Am. Chem. Soc. 120:1998;4410-4416.
25. Barkhuijsen H., DeBeer R., Bovée W.M.M.J., Van Ormondt D.J. J. Magn. Reson. 61:1985;465-481.
26. It should be noted that the spectra reported previously have quite different appearances [20]. This is because we employed another data-processing method (the maximum entropy method, MEM) in the previous report. The differences arise because the previous spectra suffered from the problems intrinsic to MEM. MEM tends: (1) to eliminate weak peaks as well as noise, and (2) to assign inaccurate intensities to peaks. These are greatly improved in LPSVD, and thus the spectra presented here must be closer to reality. For details, see D.S. Stephenson, Progr. NMR Spectrosc. 20 (1988) 515-626.
27. N.D. Chasteen, in: L.J. Berliner, J. Reuben (Eds.), Biological Magnetic Resonance, vol. 3, Plenum, New York, 1981, pp. 53-84.
28. S.A. Dikanov, A.V. Astashkin, in: A.J. Hoff (Ed.), Advanced EPR. Applications in Biology and Biochemistry, Elsevier, Amsterdam, 1989, pp. 59-117.
29. Flanagan H.L., Singel D.J. J. Chem. Phys. 87:1987;5606-5616.
30. Mims W.B. Phys. Rev. B. 5:1972;2409-2419.
31. Mims W.B. Phys. Rev. B. 6:1972;3543-3545.
32. Dikanov S.A., Tyryshkin A.M., Hüttermann J., Bogumil R., Witzel H. J. Am. Chem. Soc. 117:1995;4976-4986.
33. Hsieh Y.-N., Rubenacker G.V., Chen C.P., Brown T.L. J. Am. Chem. Soc. 99:1977;1384-1389.
34. Mims W.B. Phys. Rev. 168:1968;370-389.
35. Crans D.C., Bunch R.L., Theisen L.A. J. Am. Chem. Soc. 111:1989;7597-7607.
36. Mustafi D., Telser J., Makinen M.W. J. Am. Chem. Soc. 114:1992;6219-6226.
37. Buy C., Matsui T., Andrianambinintsoa S., Sigalat C., Girault G., Zimmermann J.-L. Biochemistry. 35:1996;14281-14293.
38. Meyer J.L., Fowler B.O. Inorg. Chem. 21:1982;3029-3035.
39. Eaton G.R., Eaton S.S. J. Magn. Reson. 136:1999;63-68.